Home » Health & Medicine, News & Current Affairs, Pharmaceuticals & Biotech, Public Affairs, Science » Stents Market to Reach $16,666 Million by 2022, Globally
“Allied Market Research”
A new report published by Allied Market Research, titled, World Stents Market, projects that the world stents market would reach $16,666 million by 2022. In 2015, Coronary stents was the largest segment in terms of value, whereas peripheral stents was the dominating market segment in terms of volume.

A new report published by Allied Market Research, titled, World Stents Market, projects that the world stents market would reach $16,666 million by 2022. In 2015, Coronary stents was the largest segment in terms of value, whereas peripheral stents was the dominating market segment in terms of volume. Moreover, coronary stents market is projected to be the fastest growing segment in terms of both, value and volume, during 2016-2022. Asia-Pacific is expected to continue leading the geographic segment during the forecast period.

The major drivers of the market include increasing geriatric population and high incidence of heart failures & coronary disorders such as esophageal cancer, gall bladder cancer, and other abnormalities. In addition, technological advancements in stent systems, such as advent of bioabsorbable stents, have fueled the market growth. Continuous improvements in healthcare insurance and reimbursement is expected to boost the growth of the stents market in the developing and underdeveloped countries, says lead analyst of the report, Deepa Tatkare. However, high cost of these stents in the emerging countries is one of the major restraining factors of the market, she further added.

Read more details of the report at: https://www.alliedmarketresearch.com/stents-market

The coronary stents market has a huge potential with the presence of many players developing innovative technologies. Increasing advancements in the field of interventional cardiology coupled with the progress of minimally invasive techniques have significantly extended the potential of therapeutic applications of stents. Coronary stents such as bare metal stents, drug-eluting stents, and bioabsorbable stents can be used to treat coronary artery diseases (CAD).
Bioabsorbable stent is expected to be the fastest growing segment, registering a CAGR of 37.2% during the forecast period. The major factors fueling the market growth are increasing focus on the development of bioabsorbable stents and their high adoption rate as they can be easily absorbed in the body and do not cause restenosis/thrombosis.

Metallic biomaterial is the dominant segment due to its cost effectiveness and the efficacy of vascular healing as compared to other stents. Natural biomaterials such as animal or plant origin materials have demonstrated several advantages over synthetic biomaterials. These are biocompatible, nontoxic, may also carry specific protein binding sites, and other biochemical signals that may assist in tissue healing or integration. The world natural biomaterial stents market is expected to grow at a CAGR of 10.5% from 2016 to 2022.

Key findings of the study

  • Coronary stent was the highest revenue-generating segment, accounting for around half of the total market in 2015, and is projected to grow at a CAGR of 9.5% during the forecast period.
  • The bioabsorbable stents segment is projected to grow at a remarkable CAGR of 37.2%, owing to its growing adoption and technological advancements.
  • The world synthetic grafts market is estimated to grow at a CAGR of 6.5% from 2016 to 2022.
  • Asia-Pacific and Europe together accounted for over half of the share in the world stents market in 2015.
  • China and Japan are the leading markets in the Asia-Pacific region and are expected to continue their dominance throughout the forecast period.
  • The South Africa stents market is estimated to garner $132 million by 2022.

In the current scenario, the U.S. and Europe have the largest customer base for stent implants. However, these regions constitute only 17% share of the world population. Whereas, the Asia-Pacific region constitute around 56.4% of the human population in 2015 (Source: United Nations Department of Economic & Social Affairs); with huge geriatric population; therefore, this region exhibits huge market potential. According to the WHO, the geriatric population in the developing countries is projected to increase by 250% between 2010 and 2050, as compared to 71% in the developed countries. This is expected to increase the patient base in these regions. The Asia-Pacific region accounted for majority of the share in the world stents market in 2015, and is expected to maintain this trend throughout the forecast period. This is attributed to the increasing incidence of heart failures, changing lifestyle, improved reimbursement policies, and high adoption of advanced stents in the region.

Explore more about Medical Device Industry here: https://www.alliedmarketresearch.com/life-sciences/medical-devices-market-report

The key players in this market have adopted product development & launch as their key strategies to cater to the changing needs of the industry. Furthermore, companies have collaborated with other key players to develop cost-effective and technologically efficient stents to strengthen their market position. The key players profiled in this report include Abbott Laboratories, B. Braun Melsungen AG, Biotronik SE & Co. KG, Boston Scientific Corporation, C.R. Bard, Inc., Elixir Medical Corporation, Medtronic plc, Microport Scientific Corporation, STENTYS S.A., and Terumo Corporation.

Media Contact
Company Name: Allied Market Research
Contact Person: Sona Padmanabhan
Email: help@alliedmarketresearch.com
Phone: +1-503-894-6022
Address:5933 NE Win Sivers Drive, #205
City: Portland
State: OR
Country: United States
Website: https://www.alliedmarketresearch.com/

Comments are closed.